New research projects on Coronavirus
On 4 May the European Commission pledged to invest €1 billion from Horizon 2020 into research and innovation to fight coronavirus. This is on top of €4.1 billion invested from 2007 to 2019 through the 7th Framework Programme and Horizon 2020 to support and coordinate research on infectious diseases (e.g. Ebola, Zika).
Comprising 151 research teams from across Europe and beyond, they are now working together to develop diagnostic tests, treatments and vaccines, as well as improving preparedness and response.
A number of these projects are already delivering results
- HG nCoV19 test project developed a new portable diagnostic system to detect viral infection that gives accurate and reliable results in 30 minutes. On 20 May, they announced that they had fulfilled the necessary requirements to put it on the market.
- Prevent-nCoV project announced on 9 June, that their vaccine against COVID-19 shows promising results, having passed tests in mice. They hope to commence clinical trials before the end of the year.
- Exscalate4CoV project announced on 18 June, that an already registered generic drug used to treat osteoporosis, Raloxifene, could be an effective treatment for COVID-19 positive patients with mild or asymptomatic infection.